Patent · US Active

Powder for achieving hemostasis

US10786596B2 · kind B2 · utility

1Cited by
7References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 11, 2019
Grant dateSep 29, 2020
Priority date
Expiry dateJan 11, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2210/1042
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

In various aspects, the present disclosure pertains to methods of treating or preventing bleeding at a tissue site comprising applying a chitosan powder composition to the tissue site. In various aspects, the present disclosure pertains to chitosan powder compositions for application to a tissue site, where the powder compositions comprise a chitosan salt, a crosslinked chitosan, a derivatized chitosan, or a combination thereof. In various aspects, the disclosure pertains to catheter assemblies, which are preloaded with a chitosan powder composition and which are configured to deliver the chitosan powder composition a tissue site.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.